CardioGenics Holdings Inc. | Income Statement
Fiscal year is November-October. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
8.90
1.30
-
-
-
Cost of Goods Sold (COGS) incl. D&A
25.60
-
21.80
21.10
14.80
Gross Income
16.70
-
21.80
21.10
14.80
SG&A Expense
3,825.00
1,264.90
2,306.00
952.40
757.40
EBIT
-
1,288.80
2,327.80
973.50
772.10
Unusual Expense
1,809.30
24.90
315.70
142.10
611.40
Non Operating Income/Expense
90.70
18.90
6.70
7.10
57.00
Interest Expense
20.10
21.70
300.10
1,841.40
475.70
Pretax Income
5,761.90
1,316.50
2,936.90
2,679.90
1,916.30
Consolidated Net Income
5,761.90
1,316.50
2,936.90
2,679.90
1,916.30
Net Income
5,724.60
1,308.00
2,918.60
2,679.90
1,916.30
Net Income After Extraordinaries
5,724.60
1,308.00
2,918.60
2,679.90
1,916.30
Net Income Available to Common
5,724.60
1,308.00
2,918.60
2,679.90
1,916.30
EPS (Basic)
0.11
0.02
0.05
0.04
0.02
Basic Shares Outstanding
54,167.70
55,629.00
57,171.90
61,701.80
94,424.00
EPS (Diluted)
0.11
0.02
0.05
0.04
0.02
Diluted Shares Outstanding
54,167.70
55,629.00
57,171.90
61,701.80
94,424.00
EBITDA
3,816.10
1,263.60
2,306.00
952.40
757.40
Minority Interest Expense
37.30
8.40
18.30
-
-
About CardioGenics Holdings
View Profile
